<DOC>
	<DOCNO>NCT00714220</DOCNO>
	<brief_summary>The work Nau et . al ( Nau KL , Bromberg MB , Forshew DA , Katcha Vl . Individuals amyotrophic lateral sclerosis caloric balance despite loss mass . J Neurol Sci 1995 ; 129 :47-49 ) show patient early stage ALS initially increase body fat . Another study show advanced ALS patient mechanical ventilation actually hypometabolic , support hypothesis ALS patient ' daily oral intake calorie fail match energy requirement , thus exacerbate condition . This current study investigate compare substrate utilization use metabolic cart control ALS patient ventilatory support examine difference substrate utilization two group ALS patient control . ( Substrate utilization essentially percentage fat , carbohydrate , protein utilized body . ) The study increase understand nutritional need ALS patient improve ability provide best possible nutrition progressive illness .</brief_summary>
	<brief_title>Quantitative Measurement Nutritional Substrate Utilization Patients With Amyotrophic Lateral Sclerosis ( ALS )</brief_title>
	<detailed_description>Study group include ALS patient without respiratory failure judge FVC use either noninvasive invasive ventilation along normal control . For patient , nutritional status assess measurement weight , determination Urinary Urea Nitrogen ( via 24hr urinary sample ) , albumin pre-albumin level question regard recent weight change . In addition , ALS patient , clinical data regard age patient , duration disease , site onset along ALS-FRS ( Amyotrophic Lateral Sclerosis Functional Rating Scale ) Pulmonary function test collect . If data already available chart commonly perform routine care , data obtain patient chart . 5cc blood obtain measurement Serum albumin , pre-albumin TNF-α . Antigenic TNF-α , bioactive TNF-α receptor serum sTNF-RI TNF-RII measure use standard ELISA kit cytolytic assay . Respiratory Quotients ( RQs ) measure use metabolic cart control ALS patient . First , patient 's VCO2 VO2 measure - patient breath mask connect machine.- RQ calculate use Lavoisier Laplace 's equation : RQ = VCO2/VO2 . This , however , accurate representation considers fat carbohydrate source gas . A corrected Non-Protein RQ ( NPRQ ) RQ calculate use 24 hour urine sample measure Urinary Urea Nitrogen ( 24hr UUN ) . This tell u amount protein oxidize per 24 hour . Then , apply principle one gram urinary nitrogen represent combustion amount protein require 5.925L oxygen produce 4.75L carbon dioxide , amount oxygen carbon dioxide associate protein metabolism calculate . This calculated VO2 VCO2 subtract total measure use metabolic cart correct Non-Protein RQ calculate . The corrected respiratory quotient use calculate amount nutritional substrate utilization patient population use Table 7.2 . Non-Protein Respiratory Quotient And The Relative Quantity Of Carbohydrate And Fat Oxidized And Energy Per Liter Of Oxygen ( Appendix-I ) .v The amount ( gram ) carbohydrate fat utilized per NPRQ record . The protein catabolic rate ( PCR ) also calculate use equation : PCR= [ 24hr UUN ( g ) + 4 ] x 6.25 ( g/day ) . The clinical information along test result collect spreadsheet patient control de-identified . This spreadsheet use analysis . Primary endpoint analysis nutritional substrate utilization without respiratory compromise . Secondary endpoint include correlation composition substrate utilization patient use ventilator , patient without PEG Tube group , correlation substrate use stage illness judge ALSFRS score , weight change duration disease . This one time test procedure , patient ask return back another visit .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<mesh_term>Neurodegenerative Diseases</mesh_term>
	<criteria>Diagnosis definite possible ALS El Escorial Criteria No previously know gastrointestinal problem Patients control evidence previous gastrointestinal disease Patients unable give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Amyotrophic Lateral Sclerosis</keyword>
	<keyword>Gastric Motility</keyword>
	<keyword>Autonomic Nervous System</keyword>
	<keyword>Neurodegenerative Diseases</keyword>
	<keyword>Movement Disorders</keyword>
	<keyword>Substrate Utilization</keyword>
</DOC>